Study on Phoenixin-14 Levels in Infants of Diabetic Mothers
The study investigates the correlation between echocardiographic pathologies and serum phoenixin-14 levels in infants of diabetic mothers.
Phase III
Cardiology / Biomarker Research
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
This study could establish phoenixin-14 as a significant biomarker for cardiac issues in infants of diabetic mothers, potentially influencing future clinical practices and therapeutic strategies. Monitoring the outcomes will be crucial for understanding its implications on diagnostics and treatment pathways in cardiology.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor results for correlations between phoenixin-14 levels and cardiac findings, as well as potential follow-up studies.
Related companies & assets
Sources & Humanexa intelligence
Related Humanexa pages
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.